当前和近期的技术来量化纳米粒子治疗负载效率和表面涂层效率的目标性质
Vy Tran1, Na Nguyen1, Scott Renkes1
1Department of Bioengineering, University of Texas at Arlington, Arlington, TX 76010, USA.
Bioengineering (Basel, Switzerland)
|April 26, 2025
概括
积极向的纳米粒子承诺更好的药物输送,但面临着生产挑战. 新的单分子分析方法为一致,有效的纳米粒子疗法提供了更好的质量控制.
科学领域:
- 纳米医学是一种纳米医学.
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
背景情况:
- 积极向的纳米粒子代表了先进的药物和基因输送系统,有可能提高治疗效率.
- 产量扩大和批量一致性方面的挑战阻碍了这些纳米药物的临床转化.
- 强大的质量控制对于纳米粒子批次重复性,药物加载,向分子有效性和安全性至关重要.
研究的目的:
- 评估传统纳米粒子表征方法的局限性.
- 为纳米粒子质量控制引入新兴的单分子分析技术.
- 引导积极准纳米粒子转化到临床环境中的进步.
主要方法:
- 传统集体平均纳米粒子表征技术及其局限性的审查.
- 介绍和评估用于纳米粒子评估的单分子分析技术.
- 专注于治疗有效载荷的量化和准部分涂层效率.
主要成果:
- 传统方法在评估纳米粒子异质性和批量变异方面扎.
- 单分子分析为单个纳米粒子特性提供了详细的见解.
- 新兴技术允许精确量化药物/基因载荷和表面修饰.
结论:
- 对纳米粒子异质性的准确表征对于治疗结果至关重要.
- 单分子分析为积极准纳米粒子的质量控制提供了更高的分辨率.
- 推进特征技术是克服纳米药物的翻译障碍的关键.
更多相关视频
07:59A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
8.8K
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
1.8K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
